Neutrophils become refractory to phorbol myristate acetate when treated with Ca2+-ionophore and Ca2+.
スポンサーリンク
概要
- 論文の詳細を見る
Human neutrophils deprived of divalent cations by treatment with ionophore A23187 in the presence of ethylene glycol bis (β-aminoethylether)-N, N, N', N'-tetraacetic acid (EGTA) showed superoxide release when they were preincubated with calcium and then treated with the ionophore. The release was not observed when the ionophore was added first and then calcium was added more than 5 min later. The absence of the release in this case can be ascribed to a refractoriness of the cells to stimuli, because the cells did not release superoxide on stimulation with phorbol myristate acetate (PMA). The cells pretreated with either calcium or the ionophore alone did release superoxide on addition of PMA. The refractoriness of the cells to PMA depended on the concentrations of calcium and the ionophore and on the time interval between the two treatments. Calcium could be replaced with Cd2 but not with Mg2+, Ba2+, or Sr2+. The release of granular enzymes was observed when the depleted cells were pretreated with the ionophore and then with calcium. These observations indicate that calcium has dual effects on the superoxide release of neutrophils, i.e., it stimulates the cells and makes them refractory to stimuli, depending on the time interval after the addition of the ionophore, and it also regulates the enzyme release by a different mechanism.
- 社団法人 日本生化学会の論文
著者
-
Senju Satoru
Department Of Immunogenetics Graduate School Of Medical Sciences Kumamoto University
-
Yoshitake Junichi
Department Of Anesthesiology Faculty Of Medicine Kyushu University
-
Takeshige Koichiro
Department Of Biochemistry Faculty Of Medicine Kyushu University
-
SENJU Satoru
Departments of Biochemistry, Kyushu University School of Medicine
-
NAKAGAWARA Miwako
Departments of Anesthesiology Kyushu University School of Medicine
-
MINAKAMI Shigeki
Departments of Biochemistry, Kyushu University School of Medicine
関連論文
- Specificity, degeneracy, and molecular mimicry in antigen recognition by HLA-Class II restricted T cell receptors : implications for clinical medicine
- Cardioprotective Effect of Succinate Againtst Ischemia/Reperfusion Injury
- Identification of the H2-K^d-restricted cytotoxic T lymphocyte epitopes of a tumor-associated antigen, SPARC, which can stimulate antitumor immunity without causing autoimmune disease in mice
- DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4^+ T cells and CD8^+ T cells
- Nature of T cell recognition of self -and nonself-peptides : its implication to anti-tumor immunity
- Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population
- Percutaneous Thermocoagulation of Trigeminal Ganglion
- Involvement of p38 MAP Kinase in Not Only Activation of the Phagocyte NADPH Oxidase Induced by Formyl-methionyl-leucyl-phenylalanine but Also Determination of the Extent of the Activity
- "S1-3 Activation of the phagocyte NADPH oxidase (Regulation of biological events and occurrence of toxicity with active oxygen species and NO)
- Pluripotent stem cells as source of dendritic cells for immune therapy
- Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc^ mice
- Therapeutic effect of α-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells
- A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells
- Peptides derived from human insulin-like growth factor-II mRNA binding protein 3 can induce human leukocyte antigen-A2-restricted cytotoxic T lymphocytes reactive to cancer cells
- Neutrophils become refractory to phorbol myristate acetate when treated with Ca2+-ionophore and Ca2+.